{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:08:21Z","timestamp":1761919701136},"reference-count":14,"publisher":"Societas Neurologica Japonica","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rinsho Shinkeigaku"],"published-print":{"date-parts":[[2013]]},"DOI":"10.5692\/clinicalneurol.53.345","type":"journal-article","created":{"date-parts":[[2013,5,29]],"date-time":"2013-05-29T03:44:04Z","timestamp":1369799044000},"page":"345-350","source":"Crossref","is-referenced-by-count":6,"title":["NMDA receptor encephalitis in the course of recurrent CNS demyelinating disorders: A case report"],"prefix":"10.5692","volume":"53","author":[{"given":"Masanari","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norito","family":"Kokubun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuta","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3663","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Dalmau J, T\u00fcz\u00fcn E, Wu H, et al. Paraneoplastic anti N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007;61:25-36.","DOI":"10.1002\/ana.21050"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091-1098.","DOI":"10.1016\/S1474-4422(08)70224-2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Kruer MC, Koch TK, Bourdette DN, et al. NMDA receptor encephalitis mimicking seronegative neuromyelitis optica. Neurology 2011;74:1473-1475.","DOI":"10.1212\/WNL.0b013e3181dc1a7f"},{"key":"4"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Johnston J, Ali K, Pearson OR, et al. Multiple sclerosis: A potential association with anti-N-methyl D-aspartate receptor encephalitis. J Neurol Neurisurg Psychiatry 2010;81:e56(abstr).","DOI":"10.1136\/jnnp.2010.226340.155"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Niehusmann P, Dalmau J, Rudlowski C, et al. Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy. Arch Neurol 2009;66:458-464.","DOI":"10.1001\/archneurol.2009.5"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Dale RC, Irani SR, Briot F, et al. N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargic. Ann Neurol 2009;66:704-709.","DOI":"10.1002\/ana.21807"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Iizuka T, Sakai F, Ide T, et al. Anti-NMDA receptor encephalitis in Japan: Long-term outcome without tumor removal. Neurology 2008;70:504-511.","DOI":"10.1212\/01.wnl.0000278388.90370.c3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Florance NR, Davis RL, Lam C, et al. Anti-N-methyl D-aspartate Receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009;66:11-18.","DOI":"10.1002\/ana.21756"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald Criteria. Ann Neurol 2011;69:292-302.","DOI":"10.1002\/ana.22366"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation predict conversion to clinically definite multiple sclerosis. Brain 1997;120:2059-2069.","DOI":"10.1093\/brain\/120.11.2059"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Gabilondo I, Saiz A, Gal\u00e1n L, et al. Analysis of relapses in anti-NMDAR encephalitis. Neurology 2011;77:996-999.","DOI":"10.1212\/WNL.0b013e31822cfc6b"},{"key":"13"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigation in patients with anti-NMDAR encephalitis. Lancet Neurol 2011;10:63-74.","DOI":"10.1016\/S1474-4422(10)70253-2"}],"container-title":["Rinsho Shinkeigaku"],"original-title":["\u591a\u767a\u6027\u786c\u5316\u75c7\u69d8\u306e\u8133\u75c5\u5909\u3092\u304f\u308a\u304b\u3048\u3057\uff0cNMDA\u53d7\u5bb9\u4f53\u8133\u708e\u3092\u5448\u3057\u305f1\u4f8b"],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T20:06:31Z","timestamp":1621541191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/clinicalneurol\/53\/5\/53_345\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.5692\/clinicalneurol.53.345","relation":{},"ISSN":["0009-918X","1882-0654"],"issn-type":[{"value":"0009-918X","type":"print"},{"value":"1882-0654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}